Skip to main content
رجوع
Watch Compare

MAINZ BIOMED N.V.

جودة البيانات: 100%
QUCY
Nasdaq Manufacturing Chemicals
KWD 0.48
▼ KWD 0.04 (-7.71%)
القيمة السوقية: 6.00 M
السعر
KWD 0.48
القيمة السوقية
6.00 M
نطاق اليوم
KWD 0.46 — KWD 0.52
نطاق 52 أسبوعًا
KWD 0.40 — KWD 4.43
حجم التداول
545,616
فتح KWD 0.50
متوسط 50 يوم / 200 يوم
KWD 0.77
37.65% below
متوسط 50 يوم / 200 يوم
KWD 1.29
62.94% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -10.98 M
Capital efficient — spends only 0.23% of revenue on capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-2526.61%
أقل من متوسط القطاع (-53.41%)
ROIC-492.09%
Net Margin-3018.31%
Op. Margin-3004.97%

الأمان

Debt / Equity
1.49
أعلى من متوسط القطاع (0.31)
Current Ratio0.50
Interest Coverage-43.22

التقييم

PE (TTM)
-0.37
أعلى من متوسط القطاع (-1.48)
P/B Ratio9.35
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -0.4 -1.5
P/B 9.4 1.6
ROE % -2526.6 -53.4
Net Margin % -3018.3 -41.5
Rev Growth 5Y % — 1.8
D/E 1.5 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 537,080.0 Net Income (TTM) -16.21 M
ROE -2526.61% ROA -304.29%
Gross Margin 72.58% Operating Margin -3004.97%
Net Margin -3018.31% Free Cash Flow (TTM) -10.98 M
ROIC -492.09% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.49 Current Ratio 0.50
Interest Coverage -43.22 Asset Turnover 0.10
Working Capital -1.85 M Tangible Book Value -471,824
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.37 Forward P/E N/A
P/B Ratio 9.35 P/S Ratio 11.17
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -183.06%
Market Cap 6.00 M Enterprise Value 6.96 M
Per Share
EPS (Diluted TTM) -2.70 Revenue / Share 0.04
FCF / Share -0.88 OCF / Share -0.88
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.23% FCF Conversion 67.74%
SBC-Adj. FCF -12.45 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue 537,080.0
Net Income -16.21 M
EPS (Diluted) -2.70
Gross Profit 389,792.0
Operating Income -16.14 M
EBITDA —
R&D Expenses 4.91 M
SG&A Expenses —
D&A 615,720.0
Interest Expense 373,458.0
Income Tax —

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 5.33 M
Total Liabilities 4.69 M
Shareholders' Equity 641,600.0
Total Debt 956,902.0
Cash & Equivalents —
Current Assets 1.84 M
Current Liabilities 3.69 M